Table 1. Participant Characteristics.
| Characteristic | Exercise (N=22) | Control (N=18) | P-Value |
|---|---|---|---|
| Age (years) | 70 ± 6 | 68 ± 5 | 0.43 |
| Women | 18 (82) | 17 (94) | 0.36 |
| Caucasian | 20 (91) | 14 (78) | 0.38 |
| Body Weight (kg) | 79 ± 17 | 79 ± 17 | 0.94 |
| BSA (m2) | 1.85 ± 0.21 | 1.80 ± 0.18 | 0.44 |
| BMI (kg/m2) | 29.6 ± 5.7 | 31.3 ± 7.1 | 0.40 |
| NYHA class | |||
| II | 14 (64) | 12 (67) | 1.0 |
| III | 8 (36) | 6 (33) | 1.0 |
| Diastolic Function | |||
| Normal | 5 (25) | 3 (17) | 0.70 |
| Abnormal relaxation | 13 (65) | 11 (61) | 1.0 |
| Pseudonormal | 2 (10) | 4 (22) | 0.39 |
| Hx pulmonary edema | 2 (9) | 5 (28) | 0.21 |
| Diabetes mellitus | 2 (9) | 4 (22) | 0.38 |
| Hx hypertension | 18(82) | 13 (72) | 0.71 |
| Current medication | |||
| ACE-inhibitors | 7 (32) | 3 (17) | 0.46 |
| Digoxin | 4 (18) | 3 (17) | 1.0 |
| Diuretics | 12 (55) | 11 (61) | 1.0 |
| Beta-blockers | 7 (32) | 3 (17) | 0.46 |
| Calcium Antagonists | 10 (45) | 8 (44) | 1.0 |
| Nitrates | 2 (9) | 0 (0) | 0.49 |
Data are presented as mean (SD), or count (%); BSA- body surface area; BMI- body mass index; NYHA- New York Heart Association; ACE-angiotensin converting enzyme.